155 related articles for article (PubMed ID: 15905712)
1. Debate: should mesalamine be used in Crohn's disease?: comments and conclusions.
Kamm MA
Inflamm Bowel Dis; 2005 Jun; 11(6):616-7. PubMed ID: 15905712
[TBL] [Abstract][Full Text] [Related]
2. The case for using 5-aminosalicyclates in Crohn's disease: pro.
Hanauer SB
Inflamm Bowel Dis; 2005 Jun; 11(6):609-12. PubMed ID: 15905710
[TBL] [Abstract][Full Text] [Related]
3. Mesalamine derivatives in the treatment of Crohn's disease.
Harrell LE; Hanauer SB
Gastroenterol Clin North Am; 2004 Jun; 33(2):303-17, ix-x. PubMed ID: 15177540
[TBL] [Abstract][Full Text] [Related]
4. The effect of mesalamine and nicotine in the treatment of inflammatory bowel disease.
Bonapace CR; Mays DA
Ann Pharmacother; 1997; 31(7-8):907-13. PubMed ID: 9220055
[TBL] [Abstract][Full Text] [Related]
5. Mesalamine for prophylaxis of small bowel Crohn's disease recurrence.
Bauer WM; Brzezinski A; Lashner BA
Curr Gastroenterol Rep; 1999 Oct; 1(5):377-83. PubMed ID: 10980975
[TBL] [Abstract][Full Text] [Related]
6. Aminosalicylates for induction of remission or response in Crohn's disease.
Lim WC; Hanauer S
Cochrane Database Syst Rev; 2010 Dec; (12):CD008870. PubMed ID: 21154400
[TBL] [Abstract][Full Text] [Related]
7. 5-ASA therapy for active Crohn's disease: old friends, old data, and a new conclusion.
Feagan BG
Clin Gastroenterol Hepatol; 2004 May; 2(5):376-8. PubMed ID: 15118974
[No Abstract] [Full Text] [Related]
8. The case against using 5-aminosalicyclates in Crohn's disease: con.
Stange EF
Inflamm Bowel Dis; 2005 Jun; 11(6):613-5. PubMed ID: 15905711
[No Abstract] [Full Text] [Related]
9. Aminosalicylates for active disease and in the maintenance of remission in Crohn's disease.
Feagan BG
Eur J Surg; 1998 Dec; 164(12):903-9. PubMed ID: 10029385
[No Abstract] [Full Text] [Related]
10. [Improved treatment of Crohn's disease].
Nau JY
Rev Med Suisse; 2005 May; 1(18):1241. PubMed ID: 15977716
[No Abstract] [Full Text] [Related]
11. Mesalamine in the treatment of active Crohn's disease.
Dignass A; Marteau P
Gastroenterology; 2005 Jan; 128(1):245-6; author reply 246. PubMed ID: 15633152
[No Abstract] [Full Text] [Related]
12. Mesalamine maintenance therapy for Crohn's disease.
Feagan BG; McDonald JW
Gastroenterology; 2001 Feb; 120(2):585-6. PubMed ID: 11271451
[No Abstract] [Full Text] [Related]
13. Initial therapy for mild to moderate Crohn's disease: mesalamine or budesonide?
Feagan BG; Sandborn WJ
Rev Gastroenterol Disord; 2002; 2 Suppl 2():S9-15. PubMed ID: 12478239
[TBL] [Abstract][Full Text] [Related]
14. Mesalamine and relapse prevention in Crohn's disease.
Cottone M; Cammà C
Gastroenterology; 2000 Aug; 119(2):597. PubMed ID: 10960274
[No Abstract] [Full Text] [Related]
15. Mesalamine in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables.
Cammà C; Giunta M; Rosselli M; Cottone M
Gastroenterology; 1997 Nov; 113(5):1465-73. PubMed ID: 9352848
[TBL] [Abstract][Full Text] [Related]
16. Increased levels of circulating platelet derived microparticles in Crohn's disease patients.
Tziatzios G; Polymeros D; Spathis A; Triantafyllou M; Gkolfakis P; Karakitsos P; Dimitriadis G; Triantafyllou K
Scand J Gastroenterol; 2016 Oct; 51(10):1184-92. PubMed ID: 27191369
[TBL] [Abstract][Full Text] [Related]
17. Mesalazine as a maintenance treatment in Crohn's disease.
Sutherland LR; Steinhart AH
Gut; 1998 Jan; 42(1):143-4. PubMed ID: 9505902
[No Abstract] [Full Text] [Related]
18. Little benefit from mesalazine taken prophylactically after surgery for Crohn's disease.
Rutgeerts P
Gut; 2001 Apr; 48(4):452-3. PubMed ID: 11247886
[No Abstract] [Full Text] [Related]
19. Efficacy of 5-aminosalicylates for the maintenance of remission in Crohn's disease.
Akobeng AK
Am J Gastroenterol; 2011 Oct; 106(10):1857; author reply 1857-8. PubMed ID: 21979212
[No Abstract] [Full Text] [Related]
20. [5-aminosalicylic acid for induction of remission or clinical response in Crohn's disease--a survey of a Cochrane review].
Bjerrum JT; Munck LK; Nielsen OH
Ugeskr Laeger; 2011 Aug; 173(35):2110-3. PubMed ID: 21884660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
